LADA - Latent Autoimmune Diabetes in Adults
作者： Małgorzata Szelachowska
DOI:
关键词:
摘要: Latent Autoimmune Diabetes In Adults (LADA) is a form of autoimmune-mediated diabetes in adults. The progression beta-cell failure slower than childhood type 1 diabetes. Patients with LADA present more preserved function those classic diagnosis according to Immunology Society based on three features: age over 35 years, the presence at least one four circulating autoantibodies pancreatic islet cell antigens and lack requirement for insulin 6 month after diagnosis. level C-peptide secretion stimulation intravenous glucagon helped There are different opinions relation treatment LADA. Some studies suggest, that indicated time LADA, some them--when patients upon oral hypoglycemic treatment.
参考文章(28)
T. J. Wilkin, The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia. ,vol. 44, pp. 914- 922 ,(2001) , 10.1007/S001250100548
O. Rolandsson, P. G. Colman, L. C. Harrison, S. Fourlanos, F. Dotta, C. J. Greenbaum, J. P. Palmer, Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. ,vol. 48, pp. 2206- 2212 ,(2005) , 10.1007/S00125-005-1960-7
M. A. Atkinson, N. K. Maclaren, R. Luchetta, Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy Diabetes. ,vol. 39, pp. 933- 937 ,(1990) , 10.2337/DIAB.39.8.933
O. Hother-Nielsen, O. Faber, N. S. Sorensen, H. Beck-Nielsen, Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care. ,vol. 11, pp. 531- 537 ,(1988) , 10.2337/DIACARE.11.7.531
Philip E. Beales, Paolo Pozzilli, Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes-metabolism Research and Reviews. ,vol. 18, pp. 114- 117 ,(2002) , 10.1002/DMRR.262
T. Lorenzen, F. Pociot, P. Hougaard, J. Nerup, Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia. ,vol. 37, pp. 321- 327 ,(1994) , 10.1007/BF00398061
Eduardo Cabrera-Rode, Prevalence of Islet Cell Antibodies (ICA) in Diabetes Mellitus and Other Diseases in Cubans Autoimmunity. ,vol. 26, pp. 7- 9 ,(1997) , 10.3109/08916939709009545
F. J. Service, R. A. Rizza, B. R. Zimmerman, P. J. Dyck, P. C. O'Brien, L. J. Melton, The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study Diabetes Care. ,vol. 20, pp. 198- 201 ,(1997) , 10.2337/DIACARE.20.2.198
J. Nerup, T. Mandrap-Poulsen, S. Helqvist, H. U. Andersen, F. Pociot, J. I. Reimers, B. G. Cuartero, A. E. Karlsen, U. Bjerre, T. Lorenzen, On the pathogenesis of IDDM Diabetologia. ,vol. 37, ,(1994) , 10.1007/BF00400830
Rattan Juneja, Irl B. Hirsch, Ramachandra G. Naik, Barbara M. Brooks-Worrell, Carla J. Greenbaum, Jerry P. Palmer, Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism-clinical and Experimental. ,vol. 50, pp. 1008- 1013 ,(2001) , 10.1053/META.2001.25654